The drug regulator has cleared Serum Institute to begin Phase III trials for a 2-in-1 covid-flu vaccine while simultaneously approving an Omicron-specific booster, marking a transition toward seasonal ...

Nagpur: India has scientific capacity, manufacturing strength, and regulatory preparedness to develop and roll out a new ...

In his address on Friday at IIT Madras, External Affairs Minister S. Jaishankar highlighted India's pivotal role in supporting global COVID-19 vaccination efforts. Reflecting on the emotional impact ...

As has been the case each year since 2022, updated COVID-19 vaccines were released leading into the fall season, and the shots should be broadly available to people age 6 months and up. For the first ...